Actively Recruiting
Developing a Peer Support Intervention for Depression in Subjective Cognitive Decline
Led by Massachusetts General Hospital · Updated on 2025-05-12
30
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating an 8-week peer support intervention called PeersCOG for adults aged 60 and older who have depression and subjective cognitive decline. This study aims to assess how feasible, acceptable, and faithfully the peer coaching can be delivered to help manage depression in this population. The study is open-label and involves community-dwelling older adults. The intervention involves trained and supervised peer coaches providing emotional, appraisal, and informational support through weekly video chats. The peer coaches will interact with participants over 8 weeks using video and text messages. Participants may also name a study partner to support them throughout the study, though this is not required. The study will use mixed methods to evaluate the intervention. Participants will have assessments at baseline, 8 weeks, and 3 months to measure depression, subjective cognitive decline, functioning, and social factors using validated tools. Post-intervention interviews with stakeholders will take place at 8 weeks. The study monitors feasibility, acceptability, and fidelity during the intervention period. Participation includes regular contact and questionnaires over about three months.
CONDITIONS
Brief Title
Developing a Peer Support Intervention for Depression in SCD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 60 years or older
- Endorse subjective cognitive decline
- Endorse depressive symptoms
- Not currently experiencing suicidal ideation nor active, untreated manic, psychotic, or substance use disorder
- Fluent in English and able to give informed consent
You will not qualify if you...
- Meets diagnostic criteria for mild cognitive impairment or Alzheimer's dementia
- Meets diagnostic criteria for a current major depressive disorder
- History of neurological and psychiatric comorbidities such as major depressive disorder in the past 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 8 weeks
Participants engage in an 8-week intervention involving weekly video chats with trained peer coaches providing emotional, appraisal, and informational support for depression and subjective cognitive decline.
Weekly video chats
Duration - Approximately 4 weeks
Participants are assessed at 3 months after the intervention to evaluate outcomes related to depression, subjective cognitive decline, functioning, and social factors.
1 follow-up visit (remote or in-person)
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
J
Jin Hui Joo, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here